文献速递瓣膜外科

微创入路与再次胸骨切开行二尖瓣手术在既往心脏手术患者中的比较:基于荷兰心脏登记的回顾性多中心研究

Minimally invasive approach compared to resternotomy for mitral valve surgery in patients with prior cardiac surgery: retrospective multicentre study based on the Netherlands Heart Registration.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

本研究基于荷兰心脏登记数据,纳入2013至2018年间既往有心脏手术史的孤立二尖瓣手术患者290例,其中再次胸骨切开组205例、微创二尖瓣手术(MIMVS)组85例。结果显示两组30天死亡率(3.4% vs 2%,P=0.99)无显著差异,5年生存率分别为86.3%和89.4%(log-rank P=0.45),多变量分析中手术入路与中期死亡率无关[HR 0.73(0.34-1.60);P=0.44]。MIMVS组延长插管和新发心律失常发生率较低。

要点

  • 既往心脏手术后二尖瓣手术,MIMVS与再次胸骨切开短期和中期结果相当。
  • 两组30天死亡率无显著差异(3.4% vs 2%,P=0.99)。
  • MIMVS组延长插管和新发心律失常发生率较低。

主要发现

  • 两组30天死亡率无显著差异:再次胸骨切开组3.4% vs MIMVS组2%(P=0.99)。
  • 5年生存率:再次胸骨切开组86.3% vs MIMVS组89.4%(log-rank P=0.45)。
  • 多变量分析中手术入路与中期死亡率无关:HR 0.73(0.34-1.60);P=0.44。
  • MIMVS组延长插管和新发心律失常发生率较低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Mitral valve (MV) surgery after prior cardiac surgery is conventionally performed through resternotomy and associated with increased morbidity and mortality. Alternatively, MV can be approached minimally invasively [minimally invasive mitral valve surgery (MIMVS)], but longer-term follow-up of this approach for MV surgery after prior cardiac surgery is lacking. Therefore, the aim of the current study is to evaluate short- and mid-term outcomes of MIMVS versus MV surgery through resternotomy in patients with prior sternotomy, using a nationwide registry. METHODS: Patients undergoing isolated MV surgery after prior cardiac surgery between 2013 and 2018 were included. Primary outcomes were short-term morbidity and mortality and mid-term survival. Cox proportional hazard analysis was used to investigate the association between surgical approach and mortality. Propensity score matching was used to correct for potential confounders. RESULTS: In total, 290 patients underwent MV surgery after prior cardiac surgery, of whom 205 patients were operated through resternotomy and 85 patients through MIMVS. No significant differences in 30-day mortality (3.4% vs 2%, P = 0.99) were observed between both groups. Five-year survival was 86.3% in the resternotomy group, compared to 89.4% in the MIMVS group (log-rank P = 0.45). In the multivariable analysis, surgical approach showed no relation with mid-term mortality [hazard ratio 0.73 (0.34-1.60); P = 0.44]. A lower incidence of prolonged intubation and new-onset arrhythmia was observed in MIMVS. CONCLUSIONS: MV surgery after prior cardiac surgery has excellent short- and mid-term results in the Netherlands, and MIMVS and resternotomy appear to be equally efficacious. MIMVS is associated with a lower incidence of new-onset arrhythmia and prolonged intubation.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Olsthoorn JR, Heuts S, Houterman S, et al. Minimally invasive approach compared to resternotomy for mitral valve surgery in patients with prior cardiac surgery: retrospective multicentre study based on the Netherlands Heart Registration. Eur J Cardiothorac Surg. 2022. PMID: 35984295. doi:10.1093/ejcts/ezac420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。